Dr. Kyaw Kyaw Lwin, MD

Dr. Lwin practices at Clovis Community Medical Center in Clovis, California, part of Community Health System.

Dr. Lwin's NPI, 1043518665, was assigned on March 6, 2011. Dr. Lwin graduated from University Institute of Medicine 1 in 1994. Dr. Lwin holds Texas license P0430.

Dr. Lwin's primary practice is Clovis Community Medical Center, at 2755 Herndon Ave, Clovis, CA 93611 in Fresno County. The practice phone is (559) 324-4000.

Dr. Lwin's primary practice is Clovis Community Medical Center in Clovis, California, part of Community Health System. The medical group on file is Community Health Partners. Dmand AI also links Dr. Lwin to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lwin practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Lwin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Lwin's licenses on file in 4 states: Texas, California, New Mexico and Virginia.

Dmand AI lists acute diabetes, acute respiratory failure, bile duct problems, cardiac arrhythmia, cellulitis, congestive heart failure, electrolyte disorders and gastrointestinal infection among the conditions Dr. Lwin treats.

CMS data shows 759 Medicare services from Dr. Lwin across 5 procedure codes in 2024, for 252 Medicare patients. Medicare paid $52,219 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 252 Medicare patients who saw Dr. Lwin in 2024. The largest group is 75 to 84, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lwin's median patient age at 69, with 53% women.

In 2024, Dr. Lwin wrote 618 Medicare Part D claims for 170 patients. 90% of them were for generic drugs. CMS names the drug for 371 of them, across 18 drugs with 11 or more claims each, at $15,188 in total drug cost. In 2023, CMS named 301 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Lwin for performance year 2024, reported as part of a group. Dr. Lwin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Lwin from 6 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $99.

Dr. Lwin graduated from University Institute of Medicine 1 in 1994.